Last reviewed · How we verify

NCT04099745

Comparing the Accuracy of Different Blood Glucose Monitoring Systems (CGM and FGM)

Status unknown NA Last updated 23 September 2019
What this trial tests

NA trial testing CGM in Type 2 Diabetes in 30 participants. Status unknown.

Timeline
1 October 2019
Primary endpoint
30 December 2019
1 February 2020

Quick facts

Lead sponsorNanjing First Hospital, Nanjing Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment30
Start date1 October 2019
Primary completion30 December 2019
Estimated completion1 February 2020

Drugs / interventions tested

Conditions studied

Sponsor

Nanjing First Hospital, Nanjing Medical University

Who can join

Adults 18 to 80, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the accuracy of different blood glucose monitoring systems (CGM and FGM) in diabetic patients with insufficient islet function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CGM

Trials testing the same drug.

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

Other Nanjing First Hospital, Nanjing Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04099745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing